A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19

AIMS: We carried out this prospective study of predominantly non-severe COVID-19 patients, to evaluate the influence of glycaemic status on clinical outcomes and neutralising antibody (Nab) responses, potentially relevant to the COVID-19 vaccination programme. METHODS: We included consecutive adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, David Tak Wai, Li, Yan Kiu, Lee, Chi Ho, Chow, Wing Sun, Lee, Alan Chun Hong, Tam, Anthony Raymond, Pang, Polly, Ho, Tip Yin, Cheung, Chloe Yu Yan, Fong, Carol Ho Yi, To, Kelvin Kai Wang, Tan, Kathryn Choon Beng, Woo, Yu Cho, Hung, Ivan Fan Ngai, Lam, Karen Siu Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816793/
https://www.ncbi.nlm.nih.gov/pubmed/35131374
http://dx.doi.org/10.1016/j.diabres.2022.109232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816793/
https://www.ncbi.nlm.nih.gov/pubmed/35131374
http://dx.doi.org/10.1016/j.diabres.2022.109232

Ejemplares similares